Waste Management, Inc (WM): what the price requires
At today's price, Waste Management, Inc (WM) is priced for +8.7% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/WM
Headline
| Field | Value |
|---|---|
| Ticker | WM |
| Company | Waste Management, Inc |
| Current price | $236.58/sh |
| Composition | East Tier (Collection and Disposal) 41% / West Tier (Collection and Disposal) 39% / Recycling Processing and Sales 7% / Renewable Energy 2% / Healthcare Solutions 11% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 5.9% |
| Operating margin today | 17.0% |
| Margin compression implied | -11.1pp |
| Implied growth | 8.7% |
| Multiple paid | 28x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~9.1pp (computed at the 7% minimum rate; the CAPM rate 6.8% sits below it).
Reconcile: at the x-ray's 9.3% required return this reads ~5.5 years; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +0.53σ |
| cohort percentile (of 225 peers) | 64 |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 3.17x | 5 | expensive |
| Earnings | 2.88x | 5 | expensive |
| Relative | 1.88x | 5 | expensive |
| Growth | 1.11x | 3 | expensive |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=18)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $201.13 | 1.18x | yes | FCF base $3.5B, growth 11% (input: historical growth), terminal g 4.0%, WACC 9.2%, 6yr projection |
| DCF Exit Multiple | Growth | $260.19 | 0.91x | yes | Exit EV/EBITDA: 11.1x / 13.1x / 15.1x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $210.74 | 1.12x | yes | P/E 24.27x (blended: static sector reference 20x + trailing (TTM) 34x), scenarios: 20.2x / 24.3x / 28.4x (bear / base = reference held flat / bull), EV/EBITDA 13x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $74.69 | 3.17x | yes | BV/sh $24.78, ROE (TTM) 27.9%, ke 9.3% |
| Two-Stage Excess Return | Asset | $132.20 | 1.79x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $213.88 | 1.11x | yes | Rev $25.4B, growth 11% (input: historical growth; tapered), Terminal P/S: 3.1x / 3.8x / 4.4x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $82.92 | 2.85x | yes | EPS $6.91, growth 5% (input: historical EPS growth), PEG=6.26 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $80.71 | 2.93x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $3.76B × (1−19%) / WACC 9.2% → EPV (no growth) |
| Residual Income | Asset | $112.56 | 2.10x | yes | BV $24.78 + 5yr PV of (ROE (TTM) 27.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $62.07 | 3.81x | yes | √(22.5 × EPS $6.91 × BVPS $24.78) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $235.08 | 1.01x | yes | EBITDA $7.35B × sector EV/EBITDA 13.0x |
| FCF Yield | Earnings | $86.76 | 2.73x | yes | FCF $3290.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $82.21 | 2.88x | yes | SBC-adj FCF $3.12B (FCF $3.29B − SBC $0.17B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $112.56 | 2.10x | yes | EPS $6.91 × (8.5 + 2×5.5%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $23.12 | 10.23x | yes | BV $24.78 × (ROIC 8.6% / WACC 9.2%) |
| P/Sales Sector | Relative | $125.68 | 1.88x | yes | Revenue $25.41B × sector P/S 2.0x |
| PEG Fair Value | Relative | $56.68 | 4.17x | yes | EPS $6.91 × (PEG 1.5 × growth 5.5% (input: historical EPS growth)) → PE 8.2x |
| Earnings Yield | Earnings | $74.70 | 3.17x | yes | EPS $6.91 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $23.9b |
| Net debt / NOPAT (after-tax) | 6.92x |
| Net debt / operating income (pre-tax) | 5.61x |
| Share count CAGR (buyback) | -0.8% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- The moat is structural: a 27.9 percent ROE on a thin 24.78-dollar book value reflects an irreplaceable landfill network plus contractual pricing power, with fees structured to pass through costs including an energy surcharge (FY2025 10-K, accession 0001104659-26-012049).
- Capital return is aggressive: a 14.5 percent dividend hike to 3.78 dollars annually (23rd consecutive year of increases) and a 3 billion dollar buyback, returning roughly 90 percent of 2026 free cash flow, while integrating the 7.2 billion dollar Stericycle acquisition toward a 300-million-dollar synergy run rate.
- The price clears no standard valuation frame, sitting above asset, earnings-power, peer, and growth-DCF reads, so the bet is on the durability of the moat rather than any backward-looking value, and the premium multiple offers little cushion against a re-rating.
Bull Case
The surprising number in Waste Management is the return on equity: 27.9 percent on a book value of just 24.78 dollars per share. That combination, a high return on a thin equity base, is the signature of a business with a structural moat and pricing power, not a capital-hungry industrial. The moat is physical and effectively unrepeatable: permitted landfills cannot be built in modern America at meaningful scale, so the network of disposal sites Waste Management already owns is a scarce asset that competitors cannot replicate. That scarcity translates into pricing power, and the pricing power is contractual. The company structures fees to pass through direct and indirect costs, including an energy surcharge intended to flow through to customers (FY2025 10-K, accession 0001104659-26-012049), which is why margins hold when costs rise. A business that can raise price above inflation, in a service customers cannot forgo, compounds quietly and reliably.
The second surprise is how much optionality sits inside a garbage company. Waste Management earns royalties on landfill gas, including a 15 percent royalty from its Renewable Energy segment on net operating revenue from selling renewable natural gas, renewable identification numbers, electricity, and capacity (FY2025 10-K, accession 0001104659-26-012049). The decomposing waste already in its landfills is being converted into a growing renewable-energy revenue stream at high incremental margin, a free option that the market historically underweighted. Q1 2026 showed the model working: net income rose 13.5 percent to 723 million dollars, operating EBITDA margin improved 200 basis points, and SG&A fell roughly 20 percent year over year as the Stericycle healthcare acquisition was integrated.
The capital-return program turns that durable cash into shareholder value. For 2026 Waste Management raised its dividend 14.5 percent to 3.78 dollars annually, its 23rd consecutive year of increases, and authorized a 3 billion dollar buyback, planning to return roughly 90 percent of free cash flow to shareholders while still funding tuck-in acquisitions. Implied operating growth embedded in the price is a reasonable 6.7 percent a year, well within what a pricing-plus-volume-plus-energy model can deliver. This is the textbook compounder: an irreplaceable asset base, contractual pricing power, a renewable-energy option, and a management team returning nearly all the cash.
Bear Case
The governance and capital-allocation question is where a Waste Management skeptic should focus, because the company is making aggressive promises about cash it has partly borrowed. Management has committed to returning roughly 90 percent of 2026 free cash flow to shareholders through a 14.5 percent dividend hike and a 3 billion dollar buyback, plans about 2 billion dollars of repurchases, and still wants to fund tuck-in acquisitions, all while carrying the debt from the 7.2 billion dollar Stericycle acquisition. Leverage is targeted around 3.1 times after a year of debt reduction. Returning nearly all free cash flow while still leveraged and still acquiring is a confident posture, but it leaves little margin for error: if the Stericycle synergies, targeted at a 300-million-dollar run rate by the end of 2027, come slower than planned, the company is funding its shareholder commitments and its deleveraging from the same finite stream.
The Stericycle deal itself is the capital-allocation item to scrutinize. Buying a medical-waste and document-destruction business for 7.2 billion dollars took Waste Management outside its core solid-waste competency, and large acquisitions into adjacent markets are where disciplined operators have historically destroyed value. The integration is going well so far, with SG&A down and margins up, but the synergy target is a forward promise, and the healthcare-waste market has its own regulatory and competitive dynamics that the core landfill moat does not protect. An acquisition that disappoints would weigh on both the earnings and the balance-sheet flexibility that the buyback assumes.
The valuation leaves no room for any of this to go wrong. The engine's read is unusually blunt: no valuation family reaches the price. The stock is rich on assets, on earnings power, on peer multiples, and even on forward growth, which means the price is a bet beyond what any standard frame supports. A trailing P/E near 34 sits close to a three-year high, and the zero-growth earnings-power value lands far below the price. Q1 2026 revenue of 6.23 billion dollars slightly missed estimates, a reminder that even a steady compounder can disappoint at a premium multiple, and the stock dipped on the print. When a business this good is priced for perfection, the risk is not that the business breaks but that the multiple does, and a premium-priced compounder that returns 90 percent of cash has spent the buffer that might otherwise cushion a re-rating.
Valuation
Waste Management is a high-quality compounder priced like one, and the X-ray is unusually unanimous: every method lands below the current price. The relative-valuation frame comes closest, at a blended P/E near 23 times landing around 207 dollars, just under the 214-dollar price. The growth-DCF reads, on roughly 11 percent historical growth, land in the 160-to-193-dollar range. The asset and earnings-power frames land much lower, with the zero-growth earnings-power value near 65 dollars and the simple excess-return read near 75 dollars, because Waste Management's book value per share of 24.78 dollars is small relative to its earnings, the same thin-equity, high-ROE profile that signals the moat. The engine's plain conclusion is that no family reaches the price, so the stock is a bet beyond what standard frames support.
Inverting the price gives a more forgiving read. At the current level the market is paying about 26 times company-wide operating income, which implies operating growth of roughly 6.7 percent a year for five years. For a business with contractual pricing power, an irreplaceable landfill network, and a growing renewable-energy line, 6.7 percent is achievable rather than heroic, and each one-percentage-point change in the cost of capital moves that implied growth by about 9 points, so read it directionally. The reliability of that solve is reasonable given the steady cash flows.
The honest synthesis is the tension between quality and price. On every static method Waste Management is expensive, because static methods cannot capture the durability of a regulated-scarcity moat. On the forward-growth inversion it is defensible, because the embedded growth is modest for the franchise. The investment question is whether you are willing to pay a premium that no backward-looking frame justifies for a business whose moat is among the most durable in the market. The dividend, raised for 23 straight years to a 3.78-dollar rate, pays you a real return while you hold, but the absence of any valuation floor near the price means the downside in a multiple compression is real. This is a pay-up-for-quality name, and the buyer should know that is the bet.
Catalysts
The near-term catalyst is the Stericycle integration. Waste Management is targeting a 300-million-dollar run-rate synergy by the end of 2027, and Q1 2026 already showed SG&A down roughly 20 percent and operating EBITDA margin up 200 basis points, so each quarter is a read on whether the healthcare-waste acquisition delivers the promised cost and revenue synergies. Progress on deleveraging from the roughly 3.1-times level, and confirmation of the full-year revenue guidance toward the 28.5-to-29.25-billion-dollar 2027 target, are the financial markers that the integration is on track.
The second catalyst is the renewable-energy build-out. Waste Management's landfill-gas-to-energy projects generate renewable natural gas, renewable identification numbers, and electricity, and the ramp of new facilities is a growing, high-margin revenue line whose contribution will become more visible in coming quarters. Capital allocation is itself a recurring catalyst: the pace of the 3 billion dollar buyback and any further dividend action signal management's cash-flow confidence, while the cadence of tuck-in acquisitions shows how the company balances M&A against shareholder returns. Pricing actions across the collection-and-disposal tiers, the engine of margin, are the operating metric to watch given the premium valuation.
Sources: Waste Management posts higher Q1 2026 earnings, stocktitan.net; WM announces 14.5 percent dividend increase and 3 billion buyback, investors.wm.com; Waste Management Q1 2026 EPS beat, investing.com; Waste Management analyst target after best-ever cost performance, tikr.com.
Peer Cohorts (Per Segment, With Filing Citations)
East Tier (Collection and Disposal) / West Tier (Collection and Disposal) (reported)
- WCN (WASTE CONNECTIONS, INC.)
- (no filing in the citation store)
- RSG (REPUBLIC SERVICES, INC.)
- (no filing in the citation store)
- CLH (CLEAN HARBORS, INC)
- (no filing in the citation store)
- CWST (CASELLA WASTE SYSTEMS, INC.)
- (no filing in the citation store)
Recycling Processing and Sales (reported)
- WCN (WASTE CONNECTIONS, INC.)
- (no filing in the citation store)
- RSG (REPUBLIC SERVICES, INC.)
- (no filing in the citation store)
- CWST (CASELLA WASTE SYSTEMS, INC.)
- (no filing in the citation store)
Renewable Energy (reported)
- WCN (WASTE CONNECTIONS, INC.)
- (no filing in the citation store)
- RSG (REPUBLIC SERVICES, INC.)
- (no filing in the citation store)
- CWST (CASELLA WASTE SYSTEMS, INC.)
- (no filing in the citation store)
- CLH (CLEAN HARBORS, INC)
- (no filing in the citation store)
Healthcare Solutions (reported)
- CLH (CLEAN HARBORS, INC)
- (no filing in the citation store)
- RSG (REPUBLIC SERVICES, INC.)
- (no filing in the citation store)
- WCN (WASTE CONNECTIONS, INC.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.